Wilson Sonsini Goodrich & Rosati advised Enable Injections on the deal. Enable Injections, Inc., a company developing and manufacturing the enFuse platform of investigational wearable drug...
Enable Injections’ $215 Million Series C Financing
Carbon Health’s $350 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised Carbon Health on the deal. Carbon Health announced that it raised $350 million. With the investment, Carbon Health, a leading...
Turntide’s $225 Million Financing
Wilson Sonsini Goodrich & Rosati advised Turntide Technologies on the deal. Turntide Technologies, the company responsible for the Smart Motor SystemTM, announced the completion of $225...
Sonder’s Business Combination with Gores Metropoulos II
Wilson Sonsini Goodrich & Rosati advised Sonder Holdings on the deal, while Weil advised Gores Metropoulos II, Inc. Sonder Holdings, a leading next-generation hospitality company that...